About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT03855722

Remote Ischaemic Preconditioning in Transplantation (RIPTRANS)

Remote ischemic preconditioning (RIPC) is a concept where remotely induced ischemia produces protection against ischemia-reperfusion injury in a remote organ. RIPC has been studied extensively in anim...

Lead sponsor: Helsinki University Central Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ville Sallinen, MD, PhD

CONTACT

+358-9-4711 ville.sallinen@helsinki.fi

Aki Uutela, MD

CONTACT

+358-9-4711 aki.uutela@hus.fi

Sponsors

Lead Sponsor

Helsinki University Central Hospital

Collaborators

Finska Läkaresällskapet (funding)
Academy of Finland
Helsinki University Hospital Research Funds (funding)

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Brain-dead organ donor with a plan of harvesting at least one kidney

Exclusion Criteria

•Haemodynamically unstable donor
•Age below 18 years
•Planned organ recipients are recruited to another prospective trial, which prevents participation in this trial.
•All organ recipients receiving organs (kidney, liver, pancreas-kidney, heart, lungs) from a randomized donor will be recruited providing that the recipient surgery is performed at Helsinki University Hospital, recipient is over 18 years old, and recipient gives written informed consent to participate in the trial.

Related studies

Prehabilitation in Patients on a Waiting List for a Transplant

NCT03314376 · Transplant Dysfunction

Not Yet RecruitingNA

Liver Transplantation After ex Vivo Liver Perfusion

NCT05951231 · Liver Transplant; Complications, Transplant; Failure, Liver, and more

Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients.

NCT03602807 · Transplant Dysfunction

Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

NCT00805571 · Kidney Transplant Dysfunction

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 10, 2020Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment496

Start dateMar 2019

Last updatedMar 10, 2020

Condition

Transplant Dysfunction

Locations shown

Helsinki University Hospital

Helsinki

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 10, 2020Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions